These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3827993)

  • 1. Norepinephrine applied in the paraventricular hypothalamic nucleus stimulates vasopressin release.
    Benetos A; Gavras I; Gavras H
    Brain Res; 1986 Sep; 381(2):322-6. PubMed ID: 3827993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of vasopressin by calcium microinjections in the area of the paraventricular nucleus of the hypothalamus.
    Benetos A; Gavras I; Gavras H
    Brain Res; 1987 May; 412(1):182-4. PubMed ID: 3607454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine vasopressin (AVP) depletion in neurons of the suprachiasmatic nuclei affects the AVP content of the paraventricular neurons and stimulates adrenocorticotrophic hormone release.
    Gomez F; Chapleur M; Fernette B; Burlet C; Nicolas JP; Burlet A
    J Neurosci Res; 1997 Nov; 50(4):565-74. PubMed ID: 9404718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norepinephrine regulates arginine vasopressin secretion in hypothalamic paraventricular nucleus relating with pain modulation.
    Yang J; Yuan HF; Liu WY; Zhang XX; Feng JP; Ni N; Yang DW; Song CY; Xu HT; Wang G; Song C; Lin BC
    Neuropeptides; 2009 Aug; 43(4):259-65. PubMed ID: 19573913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salusin-β in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats.
    Chen WW; Sun HJ; Zhang F; Zhou YB; Xiong XQ; Wang JJ; Zhu GQ
    Cardiovasc Res; 2013 Jun; 98(3):344-51. PubMed ID: 23400761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release.
    Veltmar A; Culman J; Qadri F; Rascher W; Unger T
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1253-60. PubMed ID: 1469631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the cardiovascular effects of L-glutamate microinjection into the hypothalamic paraventricular nucleus of unanesthetized rats.
    Busnardo C; Tavares RF; Corrêa FM
    J Neurosci Res; 2009 Jul; 87(9):2066-77. PubMed ID: 19229989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of hypothalamic paraventricular nucleus to C- and N-terminal angiotensin fragments: vasopressin release and drinking.
    Qadri F; Wolf A; Waldmann T; Rascher W; Unger T
    J Neuroendocrinol; 1998 Apr; 10(4):275-81. PubMed ID: 9630397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nervous system activation by glutamate injections into the paraventricular nucleus.
    Martin DS; Haywood JR
    Brain Res; 1992 Apr; 577(2):261-7. PubMed ID: 1535018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping study of noradrenergic stimulation of vasopressin release.
    Leibowitz SF; Eidelman D; Suh JS; Diaz S; Sladek CD
    Exp Neurol; 1990 Dec; 110(3):298-305. PubMed ID: 2249740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Through the central V2, not V1 receptors influencing the endogenous opiate peptide system, arginine vasopressin, not oxytocin in the hypothalamic paraventricular nucleus involves in the antinociception in the rat.
    Yang J; Chen JM; Song CY; Liu WY; Wang G; Wang CH; Lin BC
    Brain Res; 2006 Jan; 1069(1):127-38. PubMed ID: 16409991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contribution of angiotensinergic and cholinergic receptors in the hypothalamic paraventricular nucleus to osmotically induced AVP release.
    Qadri F; Waldmann T; Wolf A; Höhle S; Rascher W; Unger T
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1012-8. PubMed ID: 9618402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine vasopressin in hypothalamic paraventricular nucleus is transferred to the caudate nucleus to participate in pain modulation.
    Yang J; Li P; Zhang XY; Zhang J; Hao F; Pan YJ; Lu GZ; Lu L; Wang DX; Wang G; Yan FL
    Peptides; 2011 Jan; 32(1):71-4. PubMed ID: 20965220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressor response to microinjection of clonidine into the hypothalamic paraventricular nucleus in conscious rats.
    Ebihara H; Kawasaki H; Nakamura S; Takasaki K; Wada A
    Brain Res; 1993 Oct; 624(1-2):44-52. PubMed ID: 7902772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraventricular nucleus injections of noradrenaline: cardiovascular effects in conscious Long-Evans and Brattleboro rats.
    Harland D; Gardiner SM; Bennett T
    Brain Res; 1989 Sep; 496(1-2):14-24. PubMed ID: 2553199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion.
    Knigge U; Willems E; Kjaer A; Jørgensen H; Warberg J
    Endocrinology; 1999 Aug; 140(8):3713-9. PubMed ID: 10433231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine vasopressin in hypothalamic paraventricular nucleus is transferred to the nucleus raphe magnus to participate in pain modulation.
    Yang J; Yuan H; Liu W; Song C; Xu H; Wang G; Song C; Ni N; Yang D; Lin B
    Peptides; 2009 Sep; 30(9):1679-82. PubMed ID: 19520128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norepinephrine in the paraventricular nucleus stimulates corticosterone release.
    Leibowitz SF; Diaz S; Tempel D
    Brain Res; 1989 Sep; 496(1-2):219-27. PubMed ID: 2804631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.